@article{d7ef9f7ddbbc4a4b952e11d5a11f3a93,
title = "Mental health and dermatology practice in the COVID-19 pandemic",
keywords = "Anxiety/psychology, COVID-19, Depression/psychology, Dermatology, Humans, Mental Health, Physical Distancing, Physician's Role, Skin Diseases/psychology, Social Isolation/psychology, Social Support, Suicide/prevention & control, Telemedicine, United Kingdom",
author = "Georgia Lada and Peter Talbot and Anthony Bewley and {Kleyn MBChB, FRCP, MMedSci, PhD}, Elise",
note = "Funding Information: PST has received a consultancy fee for serving as an Advisory Board member for LivaNova UK Ltd in the past 3 years. AB has received travel bursaries and ad hoc consultancy payments from Abbvie, Almirall, Eli Lilly, Galderma, Janssen, Leo Pharma, Novartis, Sanofi and UCB. CEK has received honoraria/ad hoc consultancy payments from Janssen, Eli Lilly, LEO, Novartis, Abbvie, UCB and Almirall as well as research funding from Pfizer, Novartis, Janssen and Eli Lilly.",
year = "2020",
month = oct,
day = "1",
doi = "10.1111/ced.14330",
language = "English",
volume = "45",
pages = "816--817",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "John Wiley & Sons Ltd",
number = "7",
}
